Related Experiment Videos
Lithium therapy of children with chronic neutropenia
Insights
Lithium carbonate effectively treated chronic neutropenia in a select patient by boosting colony-stimulating activity and granulocyte precursors. This treatment shows promise for specific neutropenia types responsive to lithium.
Area of Science:
- Hematology
- Pharmacology
Background:
- Chronic neutropenia is a condition characterized by abnormally low levels of neutrophils.
- Understanding granulopoiesis and its regulation is crucial for developing effective treatments.
Observation:
- Lithium carbonate was administered to five children with chronic neutropenia.
- Granulocyte precursors (CFU-C) and colony-stimulating activity (CSA) were measured in blood and marrow samples.
- Different responses to lithium were observed across patient subgroups.
Findings:
- One patient with idiopathic neutropenia showed a significant therapeutic response, with increased CSA and CFU-C leading to normalized neutrophil counts.
- Patients with aplastic anemia did not improve despite increased CSA.
- A patient with Kostmann neutropenia showed increased CFU-C but no change in agranulocytosis.
Implications:
- Lithium carbonate may be a beneficial treatment for specific types of chronic neutropenia.
- Treatment success depends on lithium's ability to stimulate CSA production and the progenitor compartment's capacity for neutrophil maturation.
- Further research is warranted to identify patient subgroups most likely to benefit from lithium therapy.
Abstract:
We treated five children with chronic neutropenia using lithium carbonate and studied the effect in vivo on granulopoiesis. Granulocyte precursors (CFU-C) from blood and marrow, and colony-stimulating activity (CSA) from peripheral blood leukocytes, were assayed in a methylcellulose tissue culture system. Three patterns of response to lithium were seen. In patients with aplastic anemia (one acquired and two Fanconi's aplastic anemia) despite increased colony-stimulating activity, CFU-C numbers remained very low and the neutropenia persisted. In a patient with Kostmann neutropenia colony-stimulating activity, and blood and marrow CFU-C numbers increased, but the agranulocytosis was unchanged. An impressive therapeutic effect was seen in one patient with idiopathic neutropenia with low colony-stimulating activity who responded to lithium with an increase in colony-stimulating activity and CFU-C resulting in persisting normal neutrophil counts. Lithium appears useful in treating a select group of neutropenic patients in whom colony-stimulating activity production is responsive to lithium, and the granulocytic progenitor compartment is capable of producing mature neutrophils.